PSF biotech collaboration on structure-based drug design with ALTANA Pharma AG

18-Aug-2005 - Germany

PSF biotech announced that they have extended their pre-existing research collaboration in the field of structure-based drug design with Altana Pharma AG. PSF expresses ALTANA Pharma's target proteins and co-crystallizes them with ALTANA Pharma's own ligands. The structural elucidation of these proteins in complex with ligands allows for rapid optimization of active substances by computational approaches and for design of new and innovative drugs. Financial terms of the agreement were not disclosed.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances